Awarded

QUB/1820/19 Development of a Liposomal Formulation of a Peptide for Inhalation

Descriptions

The iABC-consortium (inhaled Antibiotics in Bronchiectasis and Cystic fibrosis) brings together world leading researchers to develop new antibiotic treatment options for people with Cystic Fibrosis (CF) and Bronchiectasis (BE), by sharing expertise and resources. The iABC program provides a unique opportunity to address a critical bottleneck in the development of antimicrobial agents for the treatment of chronic lung infection in CF and BE patients. This work has the potential to deliver new treatments which will improve quality of life and survival of CF and BE patients. As part of this program, Queens University Belfast seeks to appoint an Economic Operator to provide services to conduct liposomal formulation of a peptide for inhalation sponsored by Polyphor Ltd.

Timeline

Published Date :

14th Oct 2019 5 years ago

Deadline :

N/A

Tender Awarded :

1 Supplier

Awarded date :

25th Sep 2019

Contract Start :

N/A

Contract End :

N/A

Tender Regions

Wales

CPV Codes

85121200 - Medical specialist services

Keywords

specialist consultations

advanced diagnostics

clinical expertise

referred patient services

specialized medical fields

expert medical evaluation

disease-specific care

outpatient specialist visits

medical subspecialties

clinical second opinions

Tender Lot Details

2 Tender Lots

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Awarded

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors